Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 44

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 44
---
 NEOs.

| CEO |     | Other NEOs |

#### 2024 Compensation Decisions

#### Base Salary
Base salary levels are set with reference to both comparator group market data and individual performance. Base salaries are reviewed annually by the Committee and may be adjusted as a result of updated comparator group market information and the CEO’s assessment of an executive’s role and performance contributions, including the executive’s demonstration of the Company’s core values.

Based on these considerations, the Committee did not increase the 2024 base salaries for any of our NEOs.

| Name            |     | 2023 Base Salary |     |   |           |     | 2024 Base Salary |     |   |           |     | % of Increase |     |   |   |
|:----------------|:----|:-----------------|:----|:--|----------:|:----|:-----------------|:----|:--|----------:|:----|:--------------|:----|:--|:--|
| Gail Boudreaux  |     |                  |     | $ | 1,600,000 |     |                  |     | $ | 1,600,000 |     |               |     | — | % |
| Mark Kaye       |     |                  |     | $ |   900,000 |     |                  |     | $ |   900,000 |     |               |     | — | % |
| Peter Haytaian  |     |                  |     | $ |   950,000 |     |                  |     | $ |   950,000 |     |               |     | — | % |
| Felicia Norwood |     |                  |     | $ |   950,000 |     |                  |     | $ |   950,000 |     |               |     | — | % |
| Morgan Kendrick |     |                  |     | $ |   850,000 |     |                  |     | $ |   850,000 |     |               |     | — | % |

| 48 |

#### Executive Compensation

#### Annual Incentive Plan
2024 Plan Design, Performance Measures and Setting NEO Target AIP Awards

Our AIP is designed to recognize and reward NEOs for performance and results when the Company meets or exceeds annual performance goals established by the Committee. The 2024 AIP supports our focus on enhancing performance to achieve our purpose of improving the health of humanity and